NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/bailey-lipschultz
Sign In To follow
For those looking to pick new investments or add to positions on companies that have fallen out of bed, the time may be now.
The trio of public companies developing therapies using the technology known as Crispr outperformed peers.
While speculation about Amazon entering the health-care space has plagued the sector for months, one analyst calls the latest move “a full frontal attack.”